沃华医药
(002107)
| 流通市值：36.17亿 | | | 总市值：36.54亿 |
| 流通股本：5.71亿 | | | 总股本：5.77亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 393,349,512.77 | 219,045,381.55 | 816,952,424.84 | 624,613,354.3 |
| 营业收入 | 393,349,512.77 | 219,045,381.55 | 816,952,424.84 | 624,613,354.3 |
| 二、营业总成本 | 315,038,296 | 177,276,991.23 | 721,298,250.06 | 562,597,697.56 |
| 营业成本 | 87,147,077.98 | 48,268,449.66 | 201,114,648.37 | 155,377,134.44 |
| 税金及附加 | 6,977,293.28 | 3,817,327.3 | 14,347,228.55 | 11,028,929.36 |
| 销售费用 | 173,492,506.54 | 100,433,506.95 | 407,251,977.03 | 322,344,401.75 |
| 管理费用 | 31,133,408.22 | 16,931,758.39 | 66,129,923.71 | 49,538,847.83 |
| 研发费用 | 16,645,328.79 | 8,014,142.01 | 36,394,805.27 | 27,223,461.28 |
| 财务费用 | -357,318.81 | -188,193.08 | -3,940,332.87 | -2,915,077.1 |
| 其中:利息费用 | 18,767.58 | 10,042.82 | 62,306.1 | 51,101.52 |
| 其中:利息收入 | 394,156.78 | 210,969.29 | 4,042,283.59 | 2,982,741.76 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | - | - | 1,763,146.58 | 820,176.99 |
| 资产处置收益 | 1,502.59 | - | - | - |
| 资产减值损失(新) | -542,347.16 | 27,283.79 | -1,950,661.77 | -1,759,310.49 |
| 信用减值损失(新) | 730,014.16 | 616,524.77 | 3,113,190.19 | 4,269,743.43 |
| 其他收益 | 2,209,673.86 | 1,110,481.55 | 5,018,194.16 | 3,186,795.99 |
| 四、营业利润 | 80,710,060.22 | 43,522,680.43 | 103,598,043.94 | 68,533,062.66 |
| 加:营业外收入 | 420,480.94 | 389,712.07 | 494,594.69 | 227,689.3 |
| 减:营业外支出 | 29,225.01 | 20,827.32 | 1,713,065.74 | 276,252.61 |
| 五、利润总额 | 81,101,316.15 | 43,891,565.18 | 102,379,572.89 | 68,484,499.35 |
| 减:所得税费用 | 10,068,197.23 | 5,440,686.82 | 13,588,501.27 | 9,513,883.03 |
| 六、净利润 | 71,033,118.92 | 38,450,878.36 | 88,791,071.62 | 58,970,616.32 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 71,033,118.92 | 38,450,878.36 | 88,931,033.05 | 59,110,577.75 |
| 终止经营净利润 | - | - | -139,961.43 | -139,961.43 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 67,566,295.15 | 36,648,737.04 | 95,715,292.65 | 63,994,992.35 |
| 少数股东损益 | 3,466,823.77 | 1,802,141.32 | -6,924,221.03 | -5,024,376.03 |
| 扣除非经常损益后的净利润 | 65,959,000.12 | 35,743,706.1 | 92,106,702.57 | 61,271,092.16 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.12 | 0.06 | 0.17 | 0.11 |
| (二)稀释每股收益 | 0.12 | 0.06 | 0.17 | 0.11 |
| 九、综合收益总额 | 71,033,118.92 | 38,450,878.36 | 88,791,071.62 | 58,970,616.32 |
| 归属于母公司股东的综合收益总额 | 67,566,295.15 | 36,648,737.04 | 95,715,292.65 | 63,994,992.35 |
| 归属于少数股东的综合收益总额 | 3,466,823.77 | 1,802,141.32 | -6,924,221.03 | -5,024,376.03 |
| 公告日期 | 2026-07-16 | 2026-04-08 | 2026-01-20 | 2025-10-18 |
| 审计意见(境内) | | | 标准无保留意见 | |